Mabpharm Limited (2181.HK)
HKD 0.5
(3.13%)
HKD 0.5
(3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 87.16 Million | 55.91 Million | 82.88 Million | - | 14.07 Million | 23.92 Million |
| Cost of Revenue | 11.92 Million | 15.37 Million | 16.77 Million | - | - | - |
| Gross Profit | 75.23 Million | 40.54 Million | 66.1 Million | - | 14.07 Million | 23.92 Million |
| Operating Expenses | 75.23 Million | 239.75 Million | 350.76 Million | 163.43 Million | 210.59 Million | 147.54 Million |
| Selling, General and Administrative Expenses | 69.94 Million | 50.18 Million | 30.71 Million | 18.45 Million | 90.47 Million | 34.36 Million |
| Research and Development Expenses | 123.21 Million | 147.9 Million | 263.57 Million | 120.41 Million | 134.18 Million | 88.98 Million |
| Other Expenses | - | 41.66 Million | 56.47 Million | 24.56 Million | -14.07 Million | 1.72 Million |
| Cost and Expenses | 289.14 Million | 255.13 Million | 367.54 Million | 163.43 Million | 210.59 Million | 147.54 Million |
| Operating Income | -201.98 Million | -203.83 Million | -289.26 Million | -180.69 Million | -194.83 Million | -148.11 Million |
| Interest Expense | 9.57 Million | 7.18 Million | 2.4 Million | 3.94 Million | 7.69 Million | 4.48 Million |
| Income Tax Expense | - | -199 Thousand | 2.47 Million | 3.94 Million | 7.69 Million | -2.83 Million |
| Earnings before Tax | -209.35 Million | -210.81 Million | -291.74 Million | -184.63 Million | -202.52 Million | -152.59 Million |
| Net Income | -209.35 Million | -210.62 Million | -294.22 Million | -188.57 Million | -210.22 Million | -124.88 Million |
| Earnings Per Share Basic | -0.05 | -0.05 | -0.07 | -0.05 | -0.06 | -0.03 |
| Earnings Per Share Diluted | -0.05 | -0.05 | -0.07 | -0.05 | -0.06 | -0.03 |
| Weighted Average Shares Outstanding | 4.12 Billion | 4.12 Billion | 4.12 Billion | 4.12 Billion | 3.8 Billion | 4.12 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.12 Billion | 4.12 Billion | 4.12 Billion | 4.12 Billion | 3.8 Billion | 4.12 Billion |
| Gross Margin | 0.86 | 0.73 | 0.80 | - | 1.00 | 1.00 |
| EBIT Margin | -1.60 | -2.72 | -2.96 | - | -12.27 | -5.70 |
| Profit Margin | -2.40 | -3.77 | -3.55 | - | -14.94 | -5.22 |
| EBITDA | -139.08 Million | -152.08 Million | -245.46 Million | -169.93 Million | -172.63 Million | -107.97 Million |
| Earnings Before Tax Margin | -2.32 | -3.65 | -3.49 | - | -13.84 | -6.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 54.24 Million | 54.24 Million | 21.57 Million | 87.16 Million | 21.57 Million | 22.01 Million |
| Cost of Revenue | 7.06 Million | 7.06 Million | 2.86 Million | 11.92 Million | 2.86 Million | 3.09 Million |
| Gross Profit | 47.17 Million | 47.17 Million | 18.7 Million | 75.23 Million | 18.7 Million | 18.91 Million |
| Operating Expenses | 93.65 Million | 93.65 Million | 71.42 Million | 273.52 Million | 70.91 Million | 66.67 Million |
| Selling, General and Administrative Expenses | 65.5 Million | 65.5 Million | 39.58 Million | - | 39.58 Million | 37.41 Million |
| Research and Development Expenses | 28.14 Million | 28.14 Million | 31.84 Million | - | 31.84 Million | 29.76 Million |
| Other Expenses | - | - | - | -192 Thousand | - | - |
| Cost and Expenses | 100.71 Million | 100.71 Million | 74.29 Million | 285.44 Million | 73.77 Million | 69.77 Million |
| Operating Income | -46.47 Million | -46.47 Million | -52.72 Million | -199.69 Million | -52.72 Million | -48.27 Million |
| Interest Expense | - | - | - | 9.57 Million | - | 5.08 Million |
| Income Tax Expense | - | - | - | 60.52 Million | - | -1.00 |
| Earnings before Tax | -48.78 Million | -48.78 Million | -54.67 Million | -209.35 Million | -54.67 Million | -49.99 Million |
| Net Income | -48.78 Million | -48.78 Million | -54.67 Million | -209.35 Million | -54.67 Million | -49.99 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | - | -0.02 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 4.12 Billion | 4.12 Billion | 3.64 Billion | 4.12 Billion | 3.64 Billion | 4.12 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.12 Billion | 4.12 Billion | 4.12 Billion | 4.12 Billion | 4.12 Billion | 4.12 Billion |
| Gross Margin | 0.87 | 0.87 | 0.87 | 0.86 | 0.87 | 0.86 |
| EBIT Margin | -0.61 | -0.61 | -1.79 | - | -1.79 | -1.66 |
| Profit Margin | -0.90 | -0.90 | -2.53 | -2.40 | -2.53 | -2.27 |
| EBITDA | -33.19 Million | -33.19 Million | -38.54 Million | - | -38.54 Million | -36.51 Million |
| Earnings Before Tax Margin | -0.86 | -0.86 | -2.44 | -2.29 | -2.44 | -2.19 |
E25
CDW
FULC
BR
IAC
6857